Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial

Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added an administrative notice about government funding and site status, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:08:17.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated labels to Last Update Submitted that Met QC Criteria and Revision: v3.4.0. Removed the previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T21:49:50.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    48 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites in Arizona, California, Florida, Georgia, Iowa, Missouri, Ohio, Oregon, Pennsylvania, and Washington. Removed individual location subsections (Arizona Locations, California Locations, etc.) and updated the page footer to Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:28:44.000Z thumbnail image
  5. Check
    69 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.2, replacing Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:53.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page's footer revision tag changed from v3.2.0 to v3.3.1; this is a minor metadata update and does not affect content or features.
    Difference
    0.1%
    Check dated 2025-11-24T14:38:01.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Removed a government funding status notice that stated potential delays; core study information such as title, conditions, locations, and outcomes remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:47:43.000Z thumbnail image

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.